HuGE Literature Finder
Records
1
-
30
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I. JCO precision oncology 2022 2 6 e2100424. Krop Ian E, Jegede Opeyemi A, Grilley-Olson Juneko E, Lauring Josh D, Mitchell Edith P, Zwiebel James A, Gray Robert J, Wang Victoria, McShane Lisa M, Rubinstein Larry V, Patton David, Williams P Mickey, Hamilton Stanley R, Kono Scott A, Ford James M, Garcia Agustin A, Sui Xingwei D, Siegel Robert D, Slomovitz Brian M, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial. JAMA oncology 2021 Aug . Martinelli Erika, Martini Giulia, Famiglietti Vincenzo, Troiani Teresa, Napolitano Stefania, Pietrantonio Filippo, Ciardiello Davide, Terminiello Marinella, Borrelli Carola, Vitiello Pietro Paolo, De Braud Filippo, Morano Federica, Avallone Antonio, Normanno Nicola, Nappi Anna, Maiello Evaristo, Latiano Tiziana, Falcone Alfredo, Cremolini Chiara, Rossini Daniele, Santabarbara Giuseppe, Pinto Carmine, Santini Daniele, Cardone Claudia, Zanaletti Nicoletta, Di Liello Alessandra, Renato Daniela, Esposito Lucia, Marrone Francesca, Ciardiello Fortuna |
| Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Journal of clinical laboratory analysis 2021 Aug e23818. Xu Xiaojing, Huang Fei, Cao Minlu, Chen Xinning, Wang Hao, Jiang Huiqin, Yu Yiyi, Shen Minna, Yang Yihui, Wang Beili, Liu Tianshu, Guo W |
| Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer. Clinical colorectal cancer 2021 Jul . Alshammari Kanan, Aung Kyaw L, Zhang Tong, Razak Albiruni R A, Serra Stefano, Stockley Tracy, Wang Lisa, Nguyen Jessica, Spreafico Anna, Hansen Aaron R, Zwir Dave, Siu Lillian L, Bedard Philippe |
| Enhancing the landscape of colorectal cancer using targeted deep sequencing. Scientific reports 2021 Apr 11 (1): 8154. Lee Chul Seung, Song In Hye, Lee Ahwon, Kang Jun, Lee Yoon Suk, Lee In Kyu, Song Young Soo, Lee Sung H |
| Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia. PloS one 2021 16 (5): e0249590. Alharbi Amjad, Bin Dokhi Haifa, Almuhaini Ghadir, Alomran Futoon, Masuadi Emad, Alomran No |
| MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway. Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
| ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study. Neuroendocrinology 2020 Oct . Gerard Laura, Garcia Jessica, Gauthier Arnaud, Lopez Jonathan, Durand Alice, Hervieu Valérie, Lemelin Annie, Chardon Laurence, Landel Verena, Gibert Benjamin, Lombard-Bohas Catherine, Payen Lea, Walter Thom |
| Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancer. BMC cancer 2020 Sep 20 (1): 885. Jiang John, Adams Hans-Peter, Lange Maria, Siemann Sandra, Feldkamp Mirjam, McNamara Sylvie, Froehler Sebastian, Yaung Stephanie J, Yao Lijing, Balasubramanyam Aarthi, Tikoo Nalin, Ju Christine, Achenbach H Jost, Krügel Rainer, Palma John |
| Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population. Disease markers 2020 2020 8459303. El Otmani Ihsane, El Agy Fatima, El Baradai Sanae, Bouguenouch Laila, Lahmidani Nada, El Abkari Mohammed, Benajah Dafr Allah, Toughrai Imane, El Bouhaddouti Hicham, Mouaqit Ouadii, Ibn Majdoub Hassani Karim, Mazaz Khalid, Benjelloun El Bachir, Ousadden Abdelmalek, El Rhazi Karima, Bouhafa Touria, Benbrahim Zineb, Ouldim Karim, Ibrahimi Sidi Adil, Ait Taleb Khalid, Chbani Lai |
| IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER. Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery 2020 33 (3): e1524. Zanatto Renato Morato, Santos Gianni, Oliveira Júnea Caris, Pracucho Eduardo Marcucci, Nunes Adauto José Ferreira, Lopes-Filho Gaspar Jesus, Saad Sarhan Sydn |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer. Cancer biomarkers : section A of Disease markers 2019 Oct . Yu Haiying, Han Lan, Yuan Jia, Sun Yiny |
| Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line Setting. Translational oncology 2019 Mar 12 (3): 502-512. Ma Cheng-Jen, Huang Ching-Wen, Chang Tsung-Kun, Tsai Hsiang-Lin, Su Wei-Chih, Yeh Yung-Sung, Chen Po-Jung, Wang Jaw-Yu |
| Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Mar . Santos C, Azuara D, Viéitez J M, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Salazar R, Aranda |
| Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease. Endocrine 2019 Mar . Shen Chen-Tian, Zhang Guo-Qiang, Qiu Zhong-Ling, Song Hong-Jun, Sun Zhen-Kui, Luo Quan-Yo |
| EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis. Urologic oncology 2019 01 37 (1): 71-77. Huang Kang-Bo, Liu Ran-Yi, Peng Qi-Hua, Li Zai-Shang, Jiang Li-Juan, Guo Sheng-Jie, Zhou Qiang-Hua, Liu Ting-Yu, Deng Chuang-Zhong, Yao Kai, Qin Zi-Ke, Liu Zhuo-Wei, Li Yong-Hong, Han Hui, Zhou Fang-Ji |
| Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer. Molecular cancer therapeutics 2018 Oct . Wei Tao, Zhang Qi, Li Xiang, Su Wei, Li Guogang, Ma Tao, Gao Shunliang, Lou Jianying, Que Risheng, Zheng Lei, Bai Xueli, Liang Ting |
| Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Gastroenterology 2018 Sep . Bernard Vincent, Kim Dong U, San Lucas F Anthony, Castillo Jonathan, Allenson Kelvin, Mulu Feven C, Stephens Bret M, Huang Jonathan, Semaan Alexander, Guerrero Paola A, Kamyabi Nabiollah, Zhao Jun, Hurd Mark W, Koay Eugene J, Taniguchi Cullen, Herman Joseph M, Javle Milind, Wolff Robert, Katz Matthew, Varadhachary Gauri, Maitra Anirban, Alvarez Hector |
| Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients. Scientific reports 2018 Aug 8 (1): 11631. Park Gahee, Park Joo Kyung, Son Dae-Soon, Shin Seung-Ho, Kim Yeon Jeong, Jeon Hyo-Jeong, Lee Jae, Park Woong-Yang, Lee Kwang Hyuck, Park Donghy |
| Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jul . Hirsch Daniela, Wangsa Darawalee, Zhu Yuelin J, Hu Yue, Edelman Daniel C, Meltzer Paul S, Heselmeyer-Haddad Kerstin, Ott Claudia, Kienle Peter, Galata Christian, Horisberger Karoline, Ried Thomas, Gaiser Ti |
| The genetic landscape of ganglioglioma. Acta neuropathologica communications 2018 Jun 6 (1): 47. Pekmezci Melike, Villanueva-Meyer Javier E, Goode Benjamin, Van Ziffle Jessica, Onodera Courtney, Grenert James P, Bastian Boris C, Chamyan Gabriel, Maher Ossama M, Khatib Ziad, Kleinschmidt-DeMasters Bette K, Samuel David, Mueller Sabine, Banerjee Anuradha, Clarke Jennifer L, Cooney Tabitha, Torkildson Joseph, Gupta Nalin, Theodosopoulos Philip, Chang Edward F, Berger Mitchel, Bollen Andrew W, Perry Arie, Tihan Tarik, Solomon David |
| Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid. Clinical chemistry and laboratory medicine 2018 04 56 (5): 748-753. Frankel Diane, Nanni-Metellus Isabelle, Robaglia-Schlupp Andrée, Tomasini Pascale, Guinde Julien, Barlesi Fabrice, Astoul Philippe, Ouafik L'Houcine, Amatore Florent, Secq Véronique, Kaspi Elise, Roll Patri |
| Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2018 01 29 (1): 145-153. Fribbens C, Garcia Murillas I, Beaney M, Hrebien S, O'Leary B, Kilburn L, Howarth K, Epstein M, Green E, Rosenfeld N, Ring A, Johnston S, Turner |
| Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
| Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World journal of gastroenterology 2017 Aug 23 (32): 5913-5924. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Peros George, Konstantoudakis Stefanos, Leventakou Danai, Panayiotides Ioannis G, Karakitsos Petros, Koumarianou An |
| Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Aug JCO2017747576. Ramalingam Suresh S, Yang James C-H, Lee Chee Khoon, Kurata Takayasu, Kim Dong-Wan, John Thomas, Nogami Naoyuki, Ohe Yuichiro, Mann Helen, Rukazenkov Yuri, Ghiorghiu Serban, Stetson Daniel, Markovets Aleksandra, Barrett J Carl, Thress Kenneth S, Jänne Pasi |
| Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP). Targeted oncology 2017 Jun . Cardona Andrés F, Arrieta Oscar, Zapata Martín Ignacio, Rojas Leonardo, Wills Beatriz, Reguart Noemí, Karachaliou Niki, Carranza Hernán, Vargas Carlos, Otero Jorge, Archila Pilar, Martín Claudio, Corrales Luis, Cuello Mauricio, Ortiz Carlos, Pino Luis E, Rosell Rafael, Zatarain-Barrón Zyanya Lucia, |
| Telomere shortening in non-tumorous and tumor mucosa is independently related to colorectal carcinogenesis in precancerous lesions. International journal of molecular epidemiology and genetics 2017 8 (5): 53-58. Park Won-Jin, Bae Sung Uk, Heo Yu-Ran, Jung Soo-Jung, Lee Jae- |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: